Search Results 31-40 of 13695 for direct bilirubin

1. A Study To Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy For Patients With Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Total bilirubin ≤ 1.5 upper limit of normal (ULN), or if total bilirubin is > 1.5 ULN, the direct bilirubin must be normal;; Aspartate transaminase (AST) 3 ...

2. A Phase 2 Study Of CPI-0610 With And Without Ruxolitinib In Patients With Myelofibrosis - Mayo Clinic

   Life expectancy of >24 weeks. Serum direct bilirubin < 2.0 x ULN; AST and ALT ≤ 2.5 x ULN. The AST and /or ALT may be. elevated up to 5 x ULN if the ...

3. A Study To Measure Hemolysis Markers In Subjects With Warm Autoimmune Hemolytic Anemia - Mayo Clinic

   ... bilirubin, haptoglobin, and reticulocyte count), complement activation, and direct antiglobulin test (DAT), from subjects with Warm Autoimmune Hemolytic ...

4. Study To Investigate The Safety And Effectiveness Of Two Doses Of The Antibody Drug GSK2857916 In Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Total bilirubin <=1.5X Upper limit of normal (ULN). Isolated bilirubin >=1.5xULN is acceptable if bilirubin is fractionated and direct bilirubin <35 percent); ...

5. A Phase 1 Study Evaluating The Safety, PK, And Clinical Effects Of PT-112 In Subjects With Advanced Solid Tumors

   Total bilirubin ≤ 1.5 × the upper limit of normal (ULN) (subjects with Gilbert's Syndrome are allowed if direct bilirubin is within normal limits); ...

6. Biliary atresia - Symptoms and causes - Mayo Clinic

   Typical newborn jaundice is caused by a temporary buildup of bilirubin and resolves on its own. But jaundice from biliary atresia results from blocked bile ...

7. A Study Of Parsaclisib In Combination With Ruxolitinib To Treat Subjects With Myelofibrosis - Mayo Clinic

   Direct bilirubin ≥ 2.0 × the upper limit of laboratory normal (ULN);. NOTE: direct bilirubin will only be determined if total bilirubin is ≥ 2.0 × ULN.

8. A Study Of Parsaclisib In Combination With Ruxolitinib To Treat Subjects With Myelofibrosis - Mayo Clinic

   Direct bilirubin ≥ 2.0 × the upper limit of laboratory normal (ULN);. NOTE: direct bilirubin will only be determined if total bilirubin is ≥ 2.0 × ULN.

9. Safety Study Of OA-235i In Subjects With Nonalcoholic Steatohepatitis - Mayo Clinic

   Direct Bilirubin > ULN;. [NOTE: Subjects with a history of Gilbert syndrome would be eligible for this study provided direct bilirubin level is ≤ULN plus ...

10. A Study Of MT-0169 In Participants With Relapsed Or Refractory Multiple Myeloma Or Non-Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Total bilirubin ≤ 1.5*the upper limit of the normal range (ULN), except for participant with Gilbert's syndrome, in whom the direct ...